BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21490239)

  • 1. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
    Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
    Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
    Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
    Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
    BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
    Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
    Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
    Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
    Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.